Pharma Journalist -

INC Research and inVentiv Health announced that their Boards of Directors have  approved a definitive merger agreement pursuant to which their businesses would combine in an all-stock…
Read More...

Proteon Therapeutics announced that FDA has awarded Breakthrough Therapy Designation to vonapanitase (investigational treatment) for increasing arteriovenous fistula secondary patency…
Read More...

Takeda Pharmaceutical signed contract with GammaDelta Therapeutics for collaboration to develop GammaDelta Therapeutics' novel T cell platform based on the unique properties of gamma…
Read More...

ANI Pharmaceuticals, Inc. announced the launch of its first Pindolol Tablets, 5mg and 10mg. ANI's President and CEO, Arthur S. Przybyl said that they are excited to launch the first…
Read More...

BioAtla, announced that Dr. Yong Ben has been appointed as Chief Medical Officer. Dr. Yong Ben joins BioAtla with over 20 years of industry and academic experience in oncology.…
Read More...

DURECT announced that it has signed a $293 Million Agreement with Sandoz to develop and market DURECT's POSIMIR (SABER-Bupivacaine) in the United States. According to the terms of…
Read More...

Cosmo Pharmaceuticals announced that clinical trial of Eleview in comparison to a standard saline solution in subjects undergoing Endoscopic Mucosal Resection (EMR) of colonic lesions…
Read More...

U.S. FDA has granted approval for MT Pharma America, Inc. RADICAVA (edaravone), as an intravenous infusion treatment for amyotrophic lateral sclerosis (ALS).  People given RADICAVA…
Read More...

Teva Pharmaceutical and Active Biotech announced that the results from the CONCERTO trial did not meet primary endpoint. The trial was based on patients with relapsing-remitting…
Read More...

BIOLASE announced that it will be initiating a search for a Chief Financial Officer as it has accepted the resignation of recent Chief Financial Officer Mark J. Nelson. Until a…
Read More...